Market Research Logo

India Coronary Stents Market – Potential & Growth Forecast to 2019

India Coronary Stents Market – Potential & Growth Forecast to 2019

India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular to Lead the Market

The coronary stent market in India was valued around $450 million in 2012 and it has grown at an impressive rate of 22% (2005-2012) backed by a rise in PCIs (Percutaneous Coronary Intervention) which is resulted from a surge in cardiovascular disease (CVD), an improvement in healthcare infrastructure and services and an increase in disposable income. An increasing penetration of DES, which is above 90%, has also boosted the market.

The market is lead by Abbott Vascular, followed by Boston Scientific. Other key players operating in the segment are Medtronic, Inc., Biotronik, Sahajanand Medical Technologies, Meril Life Sciences and Translumina Therapeutics. Johnson and Johnson's Cordis stopped selling its stents from 20011. Cordis's market was grabbed by Abbott, Medtronic and other players. Bioabsorbable stent ABSORB, which was recently launched by Abbott Vascular, has garnered a considerable traction among the medical fraternity despite its high cost compared with other stents available in the market. The patients opting for ABSORB are financially sound or have either health insurance or are entitled for reimbursement. Abbott is aggressively chasing the market through a direct-to-consumer approach (DTC).

The coronary stent market in the country will continue to grow at a faster pace due to new and upcoming private hospitals, government initiatives to improve healthcare access, an increasing number of interventional cardiologists, an explosion of healthcare insurance and a growth in usage of high value bioabsorbable stents. The anticipated progression can be attributed to growth in elderly population, improved life expectancy, lifestyle diseases and associated complications like diabetes, hypertension and obesity.

The majority of population in need of stents is not covered under health insurance or do not get reimbursements which limits the market. However, patients under the poverty line are sponsored for healthcare insurance through the state government or insurance under public and private partnership. Some state governments have put a cap on the pricing of stents; though it may limit the market in terms of value but may help increase penetration of stents. Some state governments have put a cap on the value of stents; though this may help increase penetration of stents, it may limit the market in terms of value.

Meanwhile, the market is crowded with local players. Also, Europe-based mid-sized companies sell stents at almost half the price of international brands. It makes the market more competitive for MNCs. Further, the reduction in the reimbursement rates under the Central Government Health Scheme (CGHS) is likely to force companies to lower prices in the market.

However, the main restraints to market growth are high device and procedure costs and a lack of skilled interventional cardiologists. Hospitals and distributors in the supply chain make a killing as the device is mostly used in patients for emergency treatment.

The recently published strategic market report by ABMRG, "India coronary stent market-potential and growth forecast to 2019", analyzes the coronary stent market in India. It reviews historical trends and forecasts (2005-2019) the annualized trends for sales in terms of value and volume, market growth, pricing (Average Selling Price or ASP), competitive landscape and market share. It outlines coronary pipeline products and highlights findings of the global clinical studies. It offers a cross-category comparison for the historical and forecast period. It also provides global industry developments for the last two years, including M&As, partnerships, clinical studies, pipeline, product approvals and launches, recalls and litigations, market dynamics and market drivers.


1. Table of Contents
1.1 List of Charts
1.2 List of Tables
2. Executive Summary
3. Introduction
3.1 Classification of Stents
3.2 Timeline for stents
4. Coronary Stents
4.1 Introduction
4.1.1 Coronary stents are primarily classified based on material used and its content
4.1.2 Characteristics and Complications of Coronary Stents
4.1.3 Materials Used in Coronary Stents
4.1.4 Market Drivers
5. Coronary Stents - Market Drivers
5.1 Market Drivers for Coronary Stents
5.1.1 Aging Population
5.1.2 Obesity
5.1.3 Diabetes
5.1.4 Innovation Is a Key to Success
5.1.5 Regulatory Approvals
5.1.6 Emerging Markets Would Fuel Growth Of Stents
5.1.7 Players in the Global Market and Indian Market
6. Types of Stents
6.1 Established
6.1.1 Bare Metal Stent (BMS)
6.1.2 Drug Eluting Stent (DES)
6.2 Newer Generation Stents – Bioactive and Bioabsorbable Stents
6.2.1 Bioactive Stent (BAS)
6.2.2 Bioabsorbable Stent
7. Approvals
8. Competitive Landscape - Global
9. Global Clinical Studies
9.1 Products in Development
9.2 Comparative Trials
9.3 PMS and Registry Studies
9.4 Clinical Studies for New Geography
9.5 Existing Stents in New Indications
10. India Market for Coronary Stents (2006-2019)
10.1 Coronary Stents Cross Segment Analysis
10.2 Coronary Stents Revenue ($mn) by Segment
10.3 Coronary Stents Volume (Units) by Segment
10.4 Coronary Stents Average Prices ($)
10.5 India Coronary Stents Company Shares, 2014
11. Growth of Cath Labs in India
12. India – Coronary Angioplasty Data
12.1 India Coronary Angioplasty Data (2014)
13. State and City Wise Data - # PCIs and Coronary Stents
13.1 Maharashtra
13.1.1 Mumbai – No. of PCIs in 2014
13.1.2 Pune – No. of PCIs in 2014
13.1.3 Nagpur – No. of PCIs in 2014
13.1.4 Shirdi – No. of PCIs in 2014
13.1.5 Nashik – No. of PCIs in 2014
13.1.6 Aurangabad – No. of PCIs in 2014
13.1.7 Jalgaon – No. of PCIs in 2014
13.1.8 Latur – No. of PCIs in 2014
13.1.9 Kohlapur – No. of PCIs in 2014
13.1.10 Ahmednagar – No. of PCIs in 2014
13.1.11 Solapur – No. of PCIs in 2014
13.1.12 Nanded – No. of PCIs in 2014
13.1.13 Karad – Hospital
13.1.14 Yavatmal – No. of PCIs in 2014
13.1.15 Satara – No. of PCIs in 2014
13.1.16 Akola – No. of PCIs in 2014
13.1.17 Dhule – No. of PCIs in 2014
13.1.18 Amravati – No. of PCIs in 2014
13.1.19 Baramati – No. of PCIs in 2014
13.1.20 Vaduj – No. of PCIs in 2014
13.1.21 Ratnagiri – No. of PCIs in 2014
13.1.22 Sangli – No. of PCIs in 2014
13.2 Delhi NCR
13.2.1 Delhi – No. of PCIs in 2014
13.2.2 Gurgaon – No. of PCIs in 2014
13.2.3 Faridabad – No. of PCIs in 2014
13.2.4 Noida – No. of PCIs in 2014
13.2.5 Ghaziabad – No. of PCIs in 2014
13.3 Kerala
13.3.1 Trivandrum – No. of PCIs in 2014
13.3.2 Ernakulam – No. of PCIs in 2014
13.3.3 Perintalmanna – No. of PCIs in 2014
13.3.4 Kannur – No. of PCIs in 2014
13.3.5 Kottayam – No. of PCIs in 2014
13.3.6 Trichur – No. of PCIs in 2014
13.3.7 Calicut – No. of PCIs in 2014
13.3.8 Kollam – No. of PCIs in 2014
13.3.9 Palakkad – No. of PCIs in 2014
13.3.10 Kottakkal – No. of PCIs in 2014
13.3.11 Idukki – No. of PCIs in 2014
13.3.12 Parumala – No. of PCIs in 2014
13.3.13 Tiruvalla – No. of PCIs in 2014
13.3.14 Pala – No. of PCIs in 2014
13.3.15 Pathanamthitta – No. of PCIs in 2014
13.4 Andhra Pradesh and Telangana
13.4.1 Hyderabad – No. of PCIs in 2014
13.4.2 Guntur – No. of PCIs in 2014
13.4.3 Vijayawada – No. of PCIs in 2014
13.4.4 Vizag – No. of PCIs in 2014
13.4.5 Rajahmundry – No. of PCIs in 2014
13.4.6 Tirupati – No. of PCIs in 2014
13.4.7 Nellore – No. of PCIs in 2014
13.4.8 Karimnagar – No. of PCIs in 2014
13.4.9 Kakinada – No. of PCIs in 2014
13.4.10 Eluru – No. of PCIs in 2014
13.4.11 Nizamabad – No. of PCIs in 2014
13.5 Karnataka
13.5.1 Bangalore – No. of PCIs in 2014
13.5.2 Mangalore – No. of PCIs in 2014
13.5.3 Mysore – No. of PCIs in 2014
13.5.4 Udupi – No. of PCIs in 2014
13.5.5 Shimoga – No. of PCIs in 2014
13.5.6 Dharwad – No. of PCIs in 2014
13.5.7 Kolar – No. of PCIs in 2014
13.5.8 Hubli – No. of PCIs in 2014
13.5.9 Manipal – No. of PCIs in 2014
13.6 Tamil Nadu
13.6.1 Chennai – No. of PCIs in 2014
13.6.2 Coimbatore – No. of PCIs in 2014
13.6.3 Madurai – No. of PCIs in 2014
13.6.4 Vellore – No. of PCIs in 2014
13.6.5 Erode – No. of PCIs in 2014
13.6.6 Salem – No. of PCIs in 2014
13.6.7 Tirunelveli – No. of PCIs in 2014
13.6.8 Trichy – No. of PCIs in 2014
13.6.9 Nagercoil – No. of PCIs in 2014
13.6.10 Tuticorin – No. of PCIs in 2014
13.6.11 Cuddalore – No. of PCIs in 2014
13.7 Gujarat
13.7.1 Ahmadabad – No. of PCIs in 2014
13.7.2 Surat – No. of PCIs in 2014
13.7.3 Vadodara – No. of PCIs in 2014
13.7.4 Rajkot – No. of PCIs in 2014
13.7.5 Bhavnagar – No. of PCIs in 2014
13.7.6 Mehsana – No. of PCIs in 2014
13.8 Uttar Pradesh
13.8.1 Lukhnow – No. of PCIs in 2014
13.8.2 Meerut – No. of PCIs in 2014
13.8.3 Bareilly – No. of PCIs in 2014
13.8.4 Varanasi – No. of PCIs in 2014
13.8.5 Agra – No. of PCIs in 2014
13.8.6 Allahabad – No. of PCIs in 2014
13.8.7 Kanpur – No. of PCIs in 2014
13.9 Rajasthan
13.9.1 Jaipur – No. of PCIs in 2014
13.9.2 Jodhpur – No. of PCIs in 2014
13.9.3 Kota – No. of PCIs in 2014
13.9.4 Udaipur – No. of PCIs in 2014
13.9.5 Bikaner, Sikar and Bhiwadi – No. of PCIs in 2014
13.10 Punjab
13.10.1 Jalandar – No. of PCIs in 2014
13.10.2 Ludhiana– No. of PCIs in 2014
13.10.3 Amritsar – No. of PCIs in 2014
13.10.4 Bhatinda – No. of PCIs in 2014
13.10.5 Patiala – No. of PCIs in 2014
13.10.6 Nawanshar – No. of PCIs in 2014
13.10.7 Hoshiarpur – No. of PCIs in 2014
13.11 West Bengal
13.11.1 Kolkata – No. of PCIs in 2014
13.11.2 Durgapur – No. of PCIs in 2014
13.12 Madhya Pradesh
13.12.1 Indore – No. of PCIs in 2014
13.12.2 Bhopal – No. of PCIs in 2014
13.12.3 Jabalpur and Gwalior– No. of PCIs in 2014
13.13 Chandigarh/Mohali (Ajitgarh) – No. of PCIs in 2014
13.14 Odisha
13.14.1 Bhubaneswar – No. of PCIs in 2014
13.14.2 Cuttack – No. of PCIs in 2014
13.15 Chhattisgarh
13.15.1 Raipur – No. of PCIs in 2014
13.15.2 Bilaspur and Bhilai – No. of PCIs in 2014
13.16 Goa – No. of PCIs in 2014
13.17 Uttarakhand – No. of PCIs in 2014
13.18 Jharkhand – No. of PCIs in 2014
13.19 Puducherry – No. of PCIs in 2014
13.20 Jammu & Kashmir
13.20.1 Srinagar – No. of PCIs in 2014
13.20.2 Jammu – No. of PCIs in 2014
13.21 Haryana – No. of PCIs in 2014
13.22 Bihar – No. of PCIs in 2014
13.23 Meghalaya and Assam – No. of PCIs in 2014
14. Introduction to Supply & Distribution of Coronary Stents
14.1 Disparity in Stent Prices
14.2 Malpractice in Stents
14.3 Alternative Therapies
15. Recent Global Developments
16. Appendix
16.1 Research Methodology
16.1 Information Sources
16.2 Definitions
16.3 Disclaimer
Some of the list of Charts
Chart 1: In-depth classification of stents
Chart 2: Stent milestones
Chart 3: Stent placement procedure
Chart 4: Classification of coronary stents based on nature of material
Chart 5: Desirable stent characteristics and possible complications
Chart 6: Market Drivers – Coronary Stents
Chart 7: Growth of aging population in select countries
Chart 8: IHD mortality (33,744 deaths) versus usual total cholesterol by age
Chart 9: Rate of obesity in select countries in 2010
Chart 10: IHD mortality versus total cholesterol by BMI; systolic BP
Chart 11: Global diabetes burden
Chart 12: Growth of diabetic patients in matured and growing economies
Chart 13: Generation of stents
Chart 14: DREAMS provides scaffolding and paclitaxel release up to 3 months
Chart 15: Bioabsorption process of the BVS stent and relative degradation times
Chart 16: Growth of cardiovascular companies in emerging markets
Chart 17: Public healthcare expenditure
Chart 18: Market players
Chart 19: Cobalt alloy platform - better than stainless steel
Chart 20: Evolution of polymer free DES
Chart 21: Unmet needs of DES
Chart 22: Newer generation of stents to overcome the unmet needs of BMS & DES
Chart 23: TINOX trial - late loss reduced by 39%
Chart 24: 12- and 36-month MACE composition
Chart 25: Bioabsorbable stents are expected to establish synergy between conflicting requirements
Chart 26: High unmet needs in existing stents led invention of bioactive & bioabsorbable stents
Chart 27: Completely bioabsorbable stents may have drug or may be drug free
Chart 28: India, Coronary Stents, Cross Segment Analysis, 2006-2019
1.2 List of Tables
Table 1: Commonly used materials for coronary stents
Table 2: Innovations and approvals
Table 3: Regulatory approvals
Table 4: Biodegradable polymers offers low ST & better clinical outcomes over permanent
Table 5: Stent approval status - US, EU and Japan
Table 6: Approvals between 2002 and 2009
Table 7: Competitive landscape
Table 8: Competitive landscape
Table 9: Distribution of companies in four major geographies
Table 10: Stents undergoing clinical studies for the approvals
Table 11: Comparative trials - new v/s existing stents
Table 12: Clinical comparison and comparative trials (existing vs existing)
Table 13: Clinical studies under PMS and registries
Table 14: Pending one geography
Table 15: Existing stents in new and promising indications
Table 16: India, Coronary Stents, Cross Segment Analysis, 2006-2019
Table 17: India, Coronary Stents, Revenue ($mn), 2006-2014
Table 18: India, Coronary Stents, Revenue ($mn), 2014-2019
Table 19: India, Coronary Stents, Volume (Units'000), 2006-2014
Table 20: India, Coronary Stents, Volume (Units'000), 2014-2019
Table 21: India, Coronary Stents, Average Prices ($), 2006-2014
Table 22: India, Coronary Stents, Average Prices ($), 2014-2019
Table 23: India, Coronary Stents, Company Shares (%), 2014
Table 24: Cath labs - India

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report